Peña-Cardelles JF. Letter to the editor: Triclosan in patients with inflammatory bowel disease. Med Oral Patol Oral Cir Bucal. 2022 Sep 1;27 (5):e442-3.



doi:10.4317/medoral.25407

https://dx.doi.org/doi:10.4317/medoral.25407


1. Weatherly LM, Gosse JA. Triclosan exposure, transformation, and human health effects. J Toxicol Environ Health B Crit Rev. 2017;20:447-69.

https://doi.org/10.1080/10937404.2017.1399306

PMid:29182464 PMCid:PMC6126357

2. Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, et al. A comprehensive review and update on ulcerative colitis. Dis Mon. 2019;65:100851.

https://doi.org/10.1016/j.disamonth.2019.02.004

PMid:30837080 

3. Zhang J, Walker ME, Sanidad KZ, Zhang H, Liang Y, Zhao E, et al. Microbial enzymes induce colitis by reactivating triclosan in the mouse gastrointestinal tract. Nat Commun. 2022;13:136.

https://doi.org/10.1038/s41467-021-27762-y

PMid:35013263 PMCid:PMC8748916

4. Sanidad KZ, Xiao H, Zhang G. Triclosan, a common antimicrobial ingredient, on gut microbiota and gut health. Gut Microbes. 2019;10:434-7.

https://doi.org/10.1080/19490976.2018.1546521

PMid:30453815 PMCid:PMC6546352

5. Yang H, Wang W, Romano KA, Gu M, Sanidad KZ, Kim D, et al. A common antimicrobial additive increases colonic inflammation and colitis-associated colon tumorigenesis in mice. Sci Transl Med. 2018;10:eaan4116.

https://doi.org/10.1126/scitranslmed.aan4116

PMid:29848663 PMCid:PMC6343133